Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the sustained release excipients market grown over the years?

In recent times, the market size for sustained release excipients has experienced substantial growth. The market, which was worth $1.4 billion in 2024, is expected to expand to $1.53 billion in 2025, with a compound annual growth rate (CAGR) of 9.1%. Factors like an upsurge in demand for controlled drug release, the prevalence of chronic diseases, patient adaptability and convenience, innovation in the pharmaceutical industry, and regulatory backing for extended-release formulations have contributed to the growth seen in the historic period.

What Is the forecasted market size and growth rate for the sustained release excipients market?

In the forthcoming years, the market size for sustained release excipients is predicted to witness robust expansion. The market is projected to soar to “$2.13 billion by 2029, registering a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this anticipated growth during the forecast period include the growing elderly population, increased emphasis on personalized medicine, patient adherence complications, the emergence of intricate drug formulas, advancements in treating diseases, and the worldwide development of healthcare. Noteworthy trends for the forecast period encompass patient-oriented drug delivery, partnerships for formulation development, regulatory adherence and safety, global proliferation of drug formulation methodologies, and the impact of biopharmaceuticals.

Get your sustained release excipients market report here!

https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report

What are the major factors driving growth in the sustained release excipients market?

The expanding occurrence of both chronic and acute illnesses is anticipated to drive the expansion of the sustained-release excipients market. The categorization of diseases into chronic and acute is primarily based on their duration and progression. Chronic ailments are long-standing health conditions persisting for a period typically exceeding three months. In contrast, acute ailments are marked by swift symptom onset, which may be severe but are generally short-lived, lasting from hours to weeks. Sustained-release excipients play a crucial role in the formation of pharmaceutical products for both varieties of diseases. They are effective in enhancing patient adherence, maintaining stable drug levels, reducing adverse effects, and bettering disease management, and hence, they contribute to the rising sales of sustained-release excipients. For example, as per the World Health Organization (WHO) in September 2022, the most non-communicable disease deaths were due to cardiovascular diseases, affecting 17.9 million people each year. This is followed by chronic respiratory illnesses (4.1 million), diabetes (2.0 million, including deaths due to kidney disease caused by diabetes), and cancer (9.3 million). Furthermore, according to an August 2022 report by the American College of Cardiology, all four major cardiovascular risk factors are projected to hike from 2025 to 2060 in the United States. These include a 39.3% increase in diabetes to 55 million people, followed by dyslipidemia (27.6% rise to 126 million), hypertension (25.1% rise to 162 million), and obesity (18.3% to 126 million). Also, substantial increases in stroke (33.8% to 15 million) and heart failure (33.4% to 13 million) rates are predicted, closely trailed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). The surge in both chronic and acute diseases, therefore, fuels the development of the sustained-release excipients market.

What key areas define the segmentation of the global sustained release excipients Market?

The sustained release excipients market covered in this report is segmented –

1) By Product: Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan

2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration

3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation

Subsegments:

1) By Gelatin: Type A Gelatin, Type B Gelatin

2) By Polymers: Natural Polymers, Synthetic Polymers

3) By Minerals: Calcium Compounds, Magnesium Compounds, Other Mineral Excipients

4) By Sugars: Sucrose, Lactose, Glucose, Other Sugars

5) By Alcohol: Ethanol, Isopropyl Alcohol, Other Alcohols

6) By Chitosan: Low Molecular Weight Chitosan, High Molecular Weight Chitosan

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp

What are the top market players propelling the growth of the sustained release excipients industry?

Major companies operating in the sustained release excipients market include BASF SE, Ashland Global Holdings Inc., Colorcon Inc., Croda International Plc, Dow Chemical Company, DuPont de Nemours Inc., Roquette Frères, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, JRS Pharma GmbH & Co. KG, Shin-Etsu Chemical Co.Ltd., Gattefossé SAS, Eastman Chemical Company, Cellulose Solutions Private Limited, Avantor Inc., SPI Pharma Inc., Asahi Kasei Corporation, Chemische Fabrik Budenheim KG, Associated British Foods plc, Ransom Naturals Ltd, Balchem Corporation, IMCD Group, Lonza Group AG

What are the key trends shaping the future of the sustained release excipients market?

In the sustained release excipients market, the primary emerging trend is product innovation. Prolanza, a sustained-release ashwagandha ingredient, was launched by Nutriventia Limited, an Indian pharmaceutical company, in September 2022. The launch represents a move to solidify their market position by creating innovative products. This advanced Ashwagandha root-only extract offers ongoing stress relief. The unique release mechanism of Prolanza enables it to have long-lasting therapeutic effects from just one daily dose. Remarkably, Prolanza ashwagandha exhibited greater relative absorption, enhanced bioavailability, and a prolonged elimination half-life compared to the control component, suggestive of a sustained-release profile. Given that ashwagandha is widely used for its adaptive and stress reducing abilities, Prolanza’s therapeutic effects will have a lasting positive influence on health. Produced from natural herbs, its effectiveness has been clinically validated.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10822

What regions are dominating the sustained release excipients market growth?

North America was the largest region in the global sustained release excipients market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Animal Medicine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/animal-medicine-global-market-report

Nanomedicine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Pharmaceutical Excipients Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: